Stock 000538 YUNNAN BAIYAO GROUP CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Yunnan Baiyao Group Co.,Ltd

Equities

000538

CNE0000008X7

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
55.33 CNY 0.00% Intraday chart for Yunnan Baiyao Group Co.,Ltd -2.43% +12.57%
Apr. 26 Yunnan Baiyao Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 01 Yunnan Baiyao Group's Profit Rises 30% as Operating Income Increases MT

Business Summary

Yunnan Baiyao Group Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical products. The group proposes primarily traditional medicine products, phytobiological products, body care products, antibiotics and anti-inflammatory.

China accounts for 98.9% of net sales.

Number of employees: 8,834

Sales per Business

CNY in Million2022Weight2023Weight Delta
Wholesale and Retail
64.7 %
23,645 64.8 % 25,295 64.7 % +6.98%
Industrial Products (Homemade)
35.1 %
12,773 35.0 % 13,741 35.1 % +7.58%
Other
0.1 %
49 0.1 % 49 0.1 % +0.13%
Other Services
0.1 %
20 0.1 % 25 0.1 % +26.64%
Agricultural Products
0.0 %
2 0.0 % 1 0.0 % -9.78%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
98.4 %
36,069 98.9 % 38,477 98.4 % +6.68%
Foreign
1.6 %
419 1.1 % 634 1.6 % +51.25%

Managers

Managers TitleAgeSince
Ming Dong CEO
 Chief Executive Officer 47 21-03-02
Jia Ma DFI
 Director of Finance/CFO 47 22-05-31
Pin Yao Yin COO
 Chief Operating Officer 55 -
Yan Zhao IRC
 Investor Relations Contact - -
Wanmin Qin PRN
 Corporate Officer/Principal 60 -
Yong Yang PRN
 Corporate Officer/Principal 60 -

Members of the board

Members of the board TitleAgeSince
Yun Shan Xie BRD
 Director/Board Member 49 22-11-06
Ying Xia He BRD
 Director/Board Member 52 89-11-30
Hong Dong Lu BRD
 Director/Board Member 58 -
Yong He BRD
 Director/Board Member 54 22-11-06
Yan Hui Chen BRD
 Director/Board Member 38 19-08-20
Fa Shu Chen BRD
 Director/Board Member 64 19-08-20
Guang Hui You CHM
 Chairman 53 17-07-19
Jie Zhong BRD
 Director/Board Member 60 -
Yang Dai BRD
 Director/Board Member 55 19-08-20
Ming Dong CEO
 Chief Executive Officer 47 21-03-02

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,809,462,495 692,357,838 ( 38.26 %) 12,599,946 ( 0.6963 %) 38.26 %

Shareholders

NameEquities%Valuation
Yunnan State-Owned Assets Supervision & Admin. Commission
26.69 %
449,624,311 26.69 % 3 160 M ¥
Fa Shu Chen
25.87 %
435,742,244 25.87 % 3 063 M ¥
Government of China
8.678 %
146,185,851 8.678 % 1 028 M ¥
Jiangsu Yuyue Science & Technology Development Co. Ltd.
5.931 %
99,916,513 5.931 % 702 M ¥
UBS Asset Management (Hong Kong) Ltd.
1.531 %
25,799,172 1.531 % 181 M ¥
Yunnan Baiyao Group Co. Ltd. Esop
1.388 %
23,379,996 1.388 % 164 M ¥
UBS Asset Management (Singapore) Ltd.
1.108 %
18,672,128 1.108 % 131 M ¥
China Investment Corp. (Investment Management)
0.9864 %
16,617,440 0.9864 % 117 M ¥
E Fund Management Co., Ltd.
0.6113 %
10,297,852 0.6113 % 72 M ¥
Fullgoal Fund Management Co., Ltd.
0.2333 %
3,929,356 0.2333 % 28 M ¥
NameEquities%Valuation
Guang Ming Wu
80.03 %
89,843,113 80.03 % 631 M ¥
Fa Shu Chen
8.369 %
9,395,621 8.369 % 66 M ¥
Jin Wang
0.4489 %
504,000 0.4489 % 4 M ¥
Wanmin Qin
0.3367 %
378,000 0.3367 % 3 M ¥
Pin Yao Yin
0.2245 %
252,000 0.2245 % 2 M ¥
Yan Hui Chen
0.1185 %
133,009 0.1185 % 934 888 ¥
Juan Yu
0.0935 %
105,000 0.0935 % 738 020 ¥
Yong Yang
0.0675 %
75,768 0.0675 % 532 555 ¥
Li Jin
0.0374 %
42,000 0.0374 % 295 208 ¥
Zhaoyun Zhu
0.0374 %
42,000 0.0374 % 295 208 ¥

Holdings

NameEquities%Valuation
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
78.06%
 665,626,796 78.06% 1,559,204,145 $
JACOBSON PHARMA CORPORATION LIMITED
10.00%
 200,000,000 10.00% 15,078,000 $
SINOMAB BIOSCIENCE LIMITED
4.61%
 50,357,700 4.61% 10,037,297 $
JBM (HEALTHCARE) LIMITED
9.10%
 75,900,000 9.10% 9,212,742 $

Company contact information

Yunnan Baiyao Group Co., Ltd.

3686 Yunnan Baiyao Street Chenggong District

650500, Kunming

+

http://www.yunnanbaiyao.com.cn
address Yunnan Baiyao Group Co.,Ltd(000538)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Yunnan Baiyao Group Co.,Ltd

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
55.33 CNY
Average target price
62.1 CNY
Spread / Average Target
+12.24%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
YUNNAN BAIYAO GROUP CO.,LTD Stock Yunnan Baiyao Group Co.,Ltd
+12.57% 13.62B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000538 Stock
  4. Company Yunnan Baiyao Group Co.,Ltd